drugset / Trial / NCT01072604

Pharmacokinetic Study Comparing Aspirin and Aspirin Granules

NCT01072604

Phase 1 Completed 30 enrolled Bayer
RandomizedCrossoverOpen-labelTreatment

Summary

To determine the bioequivalence of new formula of aspirin relative to the established commercial aspirin plain tablet and aspirin dry granules when taken orally by healthy adult subjects

Timeline

Start
2009-07
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule Oral

Indications

No indication recorded.